| Home
> Table of Contents
> Case Reports |
| |
| Primary Pancreatic Lymphoma |
| |
| Urmi Chakravarty*, Shailesh Vartak*,
Cusumma Chodankar**, Nilima Ranadive*** |
| |
Primary lymphoma of the pancreas
is an exceedingly rare lesion comprising less than 0.5% of all
pancreatic tumours. Patients commonly present with abdominal
pain. The clinical and radiological findings are not pathognomonic
and diagnosis is established only after histopathologic examination.
Majority of the primary lymphomas of the pancreas are non-Hodgkin’s
lymphomas of the B cell type. This lesion responds well to aggressive
chemotherapy and hence its important to differentiate it from
pancreatic carcinoma because of the significant difference between
the treatment and prognosis of the two lesions.
|
| |
| Introduction |
Primary pancreatic lymphoma is a rare form
of extranodal lymphoma comprising less than 0.5% of pancreatic
tumours originating from the pancreatic parenchyma.1 Although
rare, this particular neoplasm is amenable to treatment
even in very advanced stages. The clinical and radiological
findings are not pathognomonic and the diagnosis is established
only after histopathologic examination.2 Abdominal pain
is the commonest presenting feature (83%), followed by
a palpable abdominal mass (58%) and weight loss (50%).3
In our case the presenting symptom was repeated episodes
of unconciousness probably due to low blood glucose levels
caused by destruction of the pancreatic tissue by the
tumour infiltration.
|
| |
| Case Report |
Our patient was a forty year old male who presented
with fever of eight days duration and complaint of episodes
of unconsciousness off and on. At the time of admission
the patient was drowsy and investigations revealed random
blood sugar levels of 40 mg%. The patient did not respond
to intravenous glucose therapy and expired within four
hours of hospital stay. An autopsy was performed.
The salient feature noted at autopsy was the presence
of a large ill-defined intra-abdominal mass measuring
8 cm x 6 cm x 5 cm. The cut section was fleshy and only
in a small area could normal appearing pancreatic tissue
be appreciated (Fig. 1). There was no tumour involvement
at any other site and neither was there any evidence of
localized or generalized lymphadenopathy.
Multiple sections from the tumour mass were studied.
Most of the sections showed a monotonous population of
small round cells in sheets separated by sparse fibrous
septae (Fig. 2). The cells had infiltrated the pancreatic
parenchyma and only isolated foci of viable pancreatic
acini were seen. The cells had scanty cytoplasm, the nuclear
chromatin was coarse and prominent nucleoli were seen
at few sites. Mitotic figures were scarce. On the basis
of light microscopy the impression given was a low grade
non-Hodgkin’s lymphoma of the pancreas.
Immunohistochemistry was done for confirming the diagnosis.
Positivity for pan B cell markers was noted. On the basis
of immunohistochemistry the tumour was typed as a primary
low grade B cell lymphoma of the pancreas
 |
 |
Fig. 1 : Large fleshy white tumour mass replacing the entire pancreas. There is no evidence of any tumour involvement in any of the adjoining organs or regional lymph nodes. |
Fig. 2 : H and E stained section showing small round cells in loose sheets separated by sparse fibrous septae (400 X). |
|
| |
| Discussion |
Primary neoplasms of the pancreas are most often adenocarcinomas.
Non-Hodgkin’s lymphomas involving the pancreas are
less common but well documented. Primary pancreatic lymphoma
is an extremely rare neoplasm that may be confused with
pancreatic adenocarcinoma.4 It is important to differentiate
between treatment and prognosis of the two conditions.
The age at presentation ranges from 37 to 74 years (our
patient was 40 year old) and abdominal pain is the commonest
presenting feature.5 However there are case reports where
there is a mention of a clinical presentation in the form
of a diabetic crisis. Since most of the case reports in
literature mention a favourable outcome following treatment
it is important to establish a definitive diagnosis for
this disease, to remove the tumour and to treat the patient
with appropriate chemotherapy.2,6
|
| |
| References |
| 1. |
Boni L, Bevnevento A, Dionigi
G, Cabrini L, Dionigi R. Primary pancreatic lymphoma.
Surg Endosc 2002 Jul; 16 (7) : 1107-8. |
| 2. |
Ezzat A, Jamshed A, Khafaga Y, et
al. Primary pancreatic non Hodgkins lymphoma. J Clin
Gastroenterol 1996 Sep.; 23 (2) : 109-12 |
| 3. |
Behrns KE, Sarr MG, Strickler JG.
Pancreatic lymphoma - is it a surgical disease. Pancreas
1994 Sep; 9 (5) : 662-7. |
| 4. |
Salvator JR, Cooper B, Shah I, Kummet
T. Primary pancreatic lymphoma: a case report, literature
review and proposal for nomenclature. Med Oncol 2000
Aug; 17 (3) : 237-47. |
| 5. |
Bouvet M, Staerkel GA, Spitz FR, et
al. Primary pancreatic lymphoma. Surgery 1998 Apr;
123 (4) : 382-90. |
| 6. |
Popescu RA, Wotherspoon AC, Cunningham
D. Local recurrence of primary pancreatic lymphoma
18 years after complete remission. Hematol Oncol 1998
Mar; 16 (1) : 29-32. |
| |
|
ANTIBIOTICS IN THE PREVENTION OF HEART ATTACKS
Reports from observational and experimental studies in human beings and animals have suggested a link between chronic infection with Chlamydia pneumoniae, an intracellular pulmonary bacterium, and cardiovascular disease. In the past year, data have emerged from three randomised trials of antichlamydial regimens. Collectively these trials exclude the possibility of all but small benefits of antichlamydial antibiotics in the secondary prevention of coronary heart disease and they encourage a critical reappraisal of the observational human evidence that started, and has helped to sustain, the hypothesis linking chlamydia and coronary heart disease.
None of the three trials reported large differences between the antibiotic-treated group and controls in the incidence of coronary heart disease endpoints.
These sobering trial data do not support a causal interpretation of associations reported between c pneumoniae markers and cardiovascular disease in observational studies.
Lancet, 2005; 330 : 365. |
|
|
|
*Lecturer; **Associate Professor; ***Professor and Head; Department of Pathology,
Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai - 400 022.
|
| |
|